MedTrace Logo

A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms

NCT02604303 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-11-29

No results posted yet for this study

Summary

Abdominal aortic aneurysm (AAA) disease is an abnormal bulging of the main abdominal artery, which is the called the abdominal aorta. The purpose of this observational study is to identify whether a blood biomarker protein RhoA can predict which small AAA patients may need surgery in the future.

Participating patients will receive an ultrasound and blood draw. The patients will be divided into expanding and stable aorta groups after determining each patient's aortic expansion rate. The blood RhoA levels and aortic expansion rates between both groups would then be compared to look for any relationships.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

OTHER

No Intervention

No intervention; prospective observational study

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • VA Northern California Health Care System

    lead FED

Principal Investigators

  • Eugene S Lee, MD, PhD · VA Northern California Health Care System

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02604303 on ClinicalTrials.gov